Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹56.55 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹56.55 Cr |
| Fresh Issue | ₹53.70 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹126.00-132.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | UNIHEALTH |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,000 shares and in multiples thereof
Incorporated in 2010, Unihealth Consultancy Limited is a healthcare service provider based out of Mumbai, India, and has an operational presence in multiple countries across the African continent.
Unihealth Consultancy's business segments include Medical Centres, Hospitals, Consultancy Services, Distribution of Pharmaceutical and medical Consumable Products, and Medical Value Travel. It operates a combined capacity of 200 operational hospital beds across two multi-specialty facilities i.e. UMC Victoria Hospital in Kampala, Uganda, has a bed strength of 120 beds, and UMC Zhahir Hospital in Kano, Nigeria has a bed strength of 80 beds. In addition to these, it operates 'Unihealth Medical Centre' a dedicated dialysis facility, in Mwanza, Tanzania.
The company is currently providing Project Management Consultancy Services to set up a 300+ bedded Health City in Undri, Pune (Maharashtra, India) for PHRC Lifespaces Organization along with a few other healthcare consultancy projects in Kenya and Angola.
Unihealth Pharmaceuticals Private Limited, a subsidiary of the company, is in the business of procuring and exporting pharmaceutical and medical consumable products. The Company exports and supplies these products mainly to Victoria Hospital Limited (Joint Venture of Unihealth Consultancy Limited) in Uganda, UMC Global Health Limited (Joint-Venture of Unihealth Consultancy Limited) in Nigeria and 114 Biohealth Limited (Subsidiary of Unihealth Consultancy Limited) in Tanzania.
The company's clientele comes from countries like India, Uganda, Nigeria & Tanzania, Kenya, Zimbabwe & Angola and Ethiopia, Mozambique & DR Congo.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in our joint venture, Victoria Hospital Limited (VHL), Kampala, Uganda for funding its capital expenditure requirements for proposed expansion and working capital requirements of VHL | 17.00 |
| 2 | Investment in our joint venture, UMC Global Health Limited (UMCGHL), Nigeria for funding its capital expenditure requirements for proposed expansion; | 4.60 |
| 3 | Investment in our subsidiary, Biohealth Limited (BL), Tanzania for funding its capital expenditure requirements for proposed expansion; and | 15.88 |
| 4 | General corporate purposes | 10.93 |
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 78.33 | 64.79 | 58.39 |
| Total Income | 46.03 | 37.93 | 28.64 |
| Profit After Tax | 7.68 | 3.82 | 5.01 |
| NET Worth | 26.13 | 14.79 | 10.70 |
| Reserves and Surplus | 26.13 | 13.45 | 9.36 |
| Total Borrowing | 39.27 | 38.01 | 38.71 |
| Amount in ₹ Crore | |||
| KPI | |
|---|---|
| ROE | 36.19% |
| ROCE | 20.99% |
| Debt / Equity | 1.43% |
| RoNW | 27.91% |
| PAT Margin | 17.48% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 6.94 | |
| P/E (x) | 19.02 | 26.56 |
| Promoter Holding | 95.32% | |
| Market Cap | ₹203.28 Cr. | |
